Other OTC - Delayed Quote USD

Invesco Markets plc - Invesco Financial S&P US Select Sector UCITS ETF (IVUSF)

305.38 0.00 (0.00%)
At close: February 27 at 3:13 PM EST
Key Events
Loading Chart for IVUSF
DELL
  • Previous Close 305.38
  • Open 305.22
  • Bid --
  • Ask --
  • Day's Range 305.38 - 305.38
  • 52 Week Range 240.46 - 305.38
  • Volume 40
  • Avg. Volume 60
  • Net Assets --
  • NAV --
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return --
  • Beta (5Y Monthly) --
  • Expense Ratio (net) --

People Also Watch

Related ETF News

Research Reports: IVUSF

  • Analyst Report: Procter & Gamble Co.

    Procter & Gamble, with headquarters in Cincinnati, and sales in over 180 countries, manufactures daily-use household, personal care, food and paper products. The company's major brands include Tide, Gillette, Pampers, Bounty, Crest, Ivory, Head & Shoulders, Scope, Oral-B, Swiffer, Tampax and Charmin. It has approximately 107,000 employees. The shares are a component of the S&P 500.

    Rating
    Price Target
     
  • Analyst Report: Accenture plc

    Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.

    Rating
    Price Target
     
  • Analyst Report: Merck KGaA

    Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

    Rating
    Price Target
     
  • Analyst Report: Merck KGaA

    Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

    Rating
    Price Target
     

Related Tickers